Walleye Capital’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-242,354
Closed -$892K 5019
2025
Q1
$892K Buy
+242,354
New +$885K ﹤0.01% 2066
2023
Q1
Sell
-33,379
Closed -$229K 4341
2022
Q4
$229K Sell
33,379
-2,835
-8% -$13.4K ﹤0.01% 1949
2022
Q3
$115K Buy
+36,214
New +$132K ﹤0.01% 2367
2022
Q1
Sell
-10,208
Closed -$46K 2582
2021
Q4
$46K Sell
10,208
-21,091
-67% -$103K ﹤0.01% 1787
2021
Q3
$205 Buy
+31,299
New +$300K 0.01% 1184
2020
Q2
Sell
-14,802
Closed -$28K 941
2020
Q1
$28K Sell
14,802
-25,562
-63% -$79.9K 0.01% 736
2019
Q4
$181K Buy
+40,364
New +$251K 0.01% 1152

Other funds holding STIM

Walleye Capital's STIM Position: Q2 2025 in Review

Walleye Capital sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 242,354 shares — an estimated $892K sold.

Walleye Capital first reported a position in STIM in Q4 2019 and held it in 7 quarters. The position peaked at $892K in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

  • Walleye Capital reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 242,354 Neuronetics shares in Q2 2025, an estimated $892K.
  • Walleye Capital first reported a position in Neuronetics in Q4 2019 and held it in 7 quarters.
  • Walleye Capital's Neuronetics position peaked at $892K in Q1 2025.
  • 90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.